keepMED is a health care startup founded in 2012, dedicated to developing a revolutionary device for the treatment of Obstructive Sleep Apnea. Their slogan, "Developing a device to provide effective treatment for Obstructive Sleep Apnea, ensuring restful nights and healthier days," encapsulates their mission to improve the quality of life for individuals suffering from this disorder. They recently secured a significant €13.00M Series C investment on 29 September 2020, with a diverse group of investors including C4 Ventures, Pitango Venture Capital, 4See Ventures, Celeste Management, Lavorel Medicare, Mérieux Equity Partners, Xenia Venture Capital, and Arbevel. This infusion of funding is poised to propel keepMED towards further innovation and expansion, ultimately making a substantial impact within the health care industry.
No recent news or press coverage available for keepMED.